HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of mutation spectrum and identification of novel mutations in ATP7B gene from a cohort of Wilson disease patients: Functional and therapeutic implications.

Abstract
Wilson disease (WD), a copper metabolism disorder, occurs due to the presence of mutations in the gene encoding ATP7B, a protein that primarily facilitates hepatic copper excretion. A better understanding of spectrum and functional significance of ATP7B variants is critical to formulating targeted and personalized therapies. Henceforth, we screened and sequenced 21 exons of ATP7B gene from 50 WD patients and 60 healthy subjects. We identified 28 variants comprising, seven novels in 20% alleles, while eight variations affecting 23% alleles were first time reported in Indian cohort. The c.813C>A, p.(Cys271*) (10%) was the most frequent mutation. Bioinformatics analysis revealed five of seven novel variants viz. c.1600C>A, p.(Pro534Thr); c.1616C>A, p.(Pro539His); c.1924G>T, p.(Asp642Tyr); c.2168G>C, p.(Arg723Thr); c.2174G>C, p.(Arg725Thr) resulted in protein misfolding. Sequence conservation analysis of ATP7B regions containing novel variants documented an evolutionarily conserved nature. Functional analysis of these novel variants in five different cell lines lacking inherent ATP7B expression demonstrated sensitivity to CuCl2 -treatment, experiencing augmented cellular copper retention and decreased copper excretion as well as ceruloplasmin secretion to that of wildtype-ATP7B expressing cells. Interestingly, pharmacological chaperone 4-phenylbutyrate, a clinically approved compound, partially restored protein function of ATP7B mutants. These findings might enable novel treatment strategies in WD by clinically enhancing the protein expression of mutant ATP7B with residual copper export activity.
AuthorsNiti Kumari, Aman Kumar, Babu Ram Thapa, Manish Modi, Arnab Pal, Rajendra Prasad
JournalHuman mutation (Hum Mutat) Vol. 39 Issue 12 Pg. 1926-1941 (12 2018) ISSN: 1098-1004 [Electronic] United States
PMID30120852 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 Wiley Periodicals, Inc.
Chemical References
  • Phenylbutyrates
  • 4-phenylbutyric acid
  • ATP7B protein, human
  • Copper-Transporting ATPases
Topics
  • Adolescent
  • Adult
  • Case-Control Studies
  • Cell Line
  • Cell Survival (drug effects)
  • Child
  • Child, Preschool
  • Cohort Studies
  • Copper-Transporting ATPases (chemistry, genetics, metabolism)
  • Female
  • HeLa Cells
  • Hepatolenticular Degeneration (genetics, metabolism)
  • Humans
  • India
  • Male
  • Mutation (drug effects)
  • Phenylbutyrates (pharmacology)
  • Polymorphism, Single Nucleotide
  • Protein Folding
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: